What is the dose of dydrogesterone (progestogen) for withdrawal bleeding after a missed period?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dydrogesterone Dosing for Withdrawal Bleeding After Missed Period

For inducing withdrawal bleeding after a missed period in premenopausal women with normal estrogen levels, dydrogesterone 10 mg daily for 14 days is the recommended dose. 1

Dosing Regimen

  • Administer dydrogesterone 10 mg daily for days 1-14 of a 28-day cycle, followed by discontinuation for days 15-28 to allow withdrawal bleeding 1

  • This regimen induces withdrawal bleeding in approximately 65% of women during the first cycle, which is twice the rate of placebo (30.8%) 1

  • Withdrawal bleeding typically occurs predictably within the 14-day hormone-free interval after stopping dydrogesterone 1, 2

Clinical Effectiveness

  • The 10 mg daily dose for 14 days has been specifically validated in premenopausal women with secondary amenorrhea and normal estrogen levels 1

  • This dosing maintains regular bleeding patterns over multiple cycles, with significantly superior regularity compared to placebo over 6 cycles 1

  • If withdrawal bleeding does not occur within 3 weeks after completing the 14-day course, pregnancy testing is advised 3

Important Clinical Considerations

  • This regimen is appropriate for women with normal estrogen levels who have missed periods but are not menopausal 1

  • The 10 mg dose provides adequate progestational transformation of the endometrium without requiring higher doses 1

  • For postmenopausal women requiring hormone replacement therapy, the same 10 mg daily dose for 12-14 days per month is used when combined with continuous estrogen 4, 5, 2

Common Pitfall to Avoid

  • Do not use doses lower than 10 mg for 14 days, as studies demonstrate that at least 10 mg for 14 days is required for acceptable endometrial protection and reliable withdrawal bleeding 6

  • Shorter durations (less than 12-14 days) provide inadequate endometrial protection and should be avoided 4

Related Questions

Is a withdrawal bleed after taking dydrogesterone (Devry) and subsequent regular periods an indication that my menstrual cycle has returned to normal after experiencing amenorrhea following the use of levonorgestrel (I pill)?
Can a female patient of reproductive age taking hormonal medications, such as contraceptives (birth control) or hormone replacement therapy (HRT), experience irregular withdrawal bleed patterns?
What is the recommended dosage and usage of dydrogesterone (progestogen)?
Does estrogen cause secondary amenorrhea?
Is the bleeding that started 34 days after a withdrawal bleed induced by dydrogesterone (a progestin) likely a menstrual period, given a negative pregnancy test result and a history of amenorrhea?
What is the recommended dosing regimen for Pneumococcal Conjugate Vaccine (PCV13) (Prevnar 13) in adults 65 years and older?
What is the most likely diagnostic test to confirm influenza in an elderly patient with fever, chills, myalgia, and bilateral interstitial infiltrates on chest radiograph, given a negative SARS-CoV-2 PCR test?
What is the recommended dosing and administration schedule for Pneumococcal Conjugate Vaccine 20 (PCV20)?
What is the most likely diagnostic test to confirm influenza in an elderly patient with fever, chills, myalgia, and bilateral interstitial infiltrates on chest radiograph, given a negative SARS-CoV-2 PCR test?
What are the drugs of choice to prevent thrombosis in an asymptomatic Antiphospholipid (APLA) triple positive patient: Aspirin + Warfarin or Aspirin + Hydroxychloroquine (HCQ)?
What is the ultrasound workup for liver schistosomiasis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.